Listas Anotadas de Medicamentos y Dispositivos
| Lista | Sección | Observación |
|---|---|---|
| Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. | Cvs Angiotensin II Antagonists | Sin observaciones |
| Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 | 01.06 ANGIOTENSIN II RECEPTOR ANTAGONIST | Sin observaciones |
| Paraguay. Lista de Medicamentos Esenciales. 2009 | 09. AGENTES QUE ACTÚAN SOBRE EL SISTEMA RENINA-ANGIOTENSINA | Sin observaciones |
| Barbados. Barbados National Drug Formulary (BNDF) | 24.32.08 Angiotensin II Receptor Antagonist | Sin observaciones |
| Bahamas. Drug Formulary | 02. CARDIOVASCULAR DRUGS | Sin observaciones |
| Cayman Islands Health Services Authority Pharmacy Drug Formulary | 02.05.04.02 Angiotensin II Receptor Antagonists | Sin observaciones |
| Lista | Sección | Observación |
|---|---|---|
| Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 | 01.06 ANGIOTENSIN II RECEPTOR ANTAGONIST | Sin observaciones |
| Mexico. Cuadro Basico de Medicamentos - 2017 | 03. CARDIOLOGIA | Sin observaciones |
| Barbados. Barbados National Drug Formulary (BNDF) | 24.32.08 Angiotensin II Receptor Antagonist | Sin observaciones |
| Bahamas. Drug Formulary | 02. CARDIOVASCULAR DRUGS | Sin observaciones |
| Cayman Islands Health Services Authority Pharmacy Drug Formulary | 02.05.04.02 Angiotensin II Receptor Antagonists | Sin observaciones |
| Lista | Sección | Observación |
|---|---|---|
| Bahamas. Drug Formulary | 02. CARDIOVASCULAR DRUGS | Sin observaciones |
| Lista | Sección | Observación |
|---|---|---|
| Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 | 01.06 ANGIOTENSIN II RECEPTOR ANTAGONIST | Sin observaciones |
| Barbados. Barbados National Drug Formulary (BNDF) | 24.32.08 Angiotensin II Receptor Antagonist | Sin observaciones |
| Bahamas. Drug Formulary | 02. CARDIOVASCULAR DRUGS | Sin observaciones |